Skip to main content

Table 1 Demographic and clinical data of patients and controls

From: An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes

A. Screening cohort analyzed in cytokine microarray experiment
  PSP/CBS MSA PD CTRL p-value
Number 10 10 20 30  
Female, n(%) 6(60) 6(60) 12(60) 18(60) nsb
Age, ya 68(54–75) 66(54–75) 67(52–81) 65(56–80) nsc
Duration, ya 4(1–8) 5(1–9) 6(1–37)   nsc
Hoehn&Yahra 3(2–5) 4(2–5) 2(1–4)   <0.001c
Dementia, n(%) 3(30) 2(20) 2(10)   nsb
Treatment, n(%) 9(90) 5(50) 18(90)   ns
  PSP/CBS MSA PD CTRL p-value
Number 28 21 97 69  
Female, n(%) 14(50) 14(67) 32(33) 29(42) 0.03b
Age, ya 74(57–84) 63(46–78) 66(41–85) 63(42–93) <0.001c
Duration, ya 3(1–11) 3(1–6) 4(0–27)   nsc
Hoehn&Yahra 4(2–5) 4(0–5) 2(0–5)   <0.001c
Dementia, n(%) 14(52) 0(0) 10(11)   <0.001b
Treatment, n(%) 19(68) 15(71) 63(65)   nsb
  1. y = years, ns = not statistically significant, treatment = patients treated with levodopa and/or dopamine agonists and/or monoamine oxidase inhibitors
  2. a data are shown as median (range), p-value: groups were compared using b Chi-Square test and c Kruskal-Wallis test.